Helvetic BioPharma is an innovative bio-pharmaceutical company based in Ticino, Switzerland.
The technology platform we apply includes the manufacturing of recombinant proteins and monoclonal antibodies for therapeutic use.
On an area of about 2000 square meters our activities of research, development, production, warehouse/utilities, QA/QC, administration and marketing are located. The therapeutic areas in which we are involved are, among the others, Oncology, Hematology, Immuno-modulation and auto-immune diseases cure.
Helvetic BioPharma has a strategic and customer-focused approach to developing, producing and marketing high-quality affordable medicines in a sustainable way.
Our worldwide commercial presence relies on many partners involved in the promotion of our products portfolio.